A Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2013
At a glance
- Drugs Radavirsen (Primary)
- Indications Influenza A virus infections; Various toxicities
- Focus Adverse reactions; Pharmacokinetics
- 10 Jun 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 21 Nov 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 21 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.